Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
How RNA is making waves in the industry – and leading to new research projects and increased demand for new manufacturing capacities.
A possible fix for problems in small molecule manufacture via continuous flow processing.
Researchers at Trinity College Dublin explain how they are reaching into the natural environment to source new bioactives.
In this video interview, Mike Rea explains why each drug needs its own launch strategy.
Emerging technologies are proving that small molecules aren't yesterday's news.
How is the field of antibody drug conjugates being reshaped?
Pharma wants to empower patients to make informed healthcare decisions, but patients also need to be protected from misinformation.
Manufacturers must look to ease the headaches associated with the manufacture of mRNA-based products.
A diverse range of malaria treatments will make all the difference in the prevention of resistance.
How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
Every Disease Has its Day
The Cutting Edge of Biopharma Analytics
It’s All About Connecting